---
title: "A phenome-wide comparative analysis of genetic discordance between obesity and type 2 diabetes"
description: |
  * **Core Finding**: The study used genetic data to define two distinct **obesity profiles** that exhibit highly contrasting, or discordant, effects on the risk of developing type 2 diabetes (T2D).
  * **Phenotypic Differences**: The two profiles showed key differences across a wide range of clinical and molecular traits, including **cardiovascular mortality**, **liver metabolism**, specific **lipid fractions**, and **blood pressure**.
  * **Mechanism**: Instrumental analyses highlighted the prominent **causal role** of factors like **waist-to-hip ratio** and **blood pressure** in driving the differences in T2D risk between the two genetic obesity subtypes.
date: last-modified
categories: [genetics, metabolism, GWAS, phenome-wide analysis]
---

**PubMed:** [36703017](https://pubmed.ncbi.nlm.nih.gov/36703017/)
**DOI:** [10.1038/s42255-022-00731-5](https://doi.org/10.1038/s42255-022-00731-5)
**Overview generated by:** Gemini 2.5 Flash, 28/11/2025

## Key Findings: Two Genetic Obesity Profiles

This study addresses the high degree of heterogeneity in the relationship between **obesity** and **type 2 diabetes (T2D)** by using a genetic-driven approach to define two distinct obesity profiles. These profiles convey **highly concordant and discordant diabetogenic effects**, indicating that the genetic mechanism of obesity strongly influences its specific consequences for metabolic health.

## Methods and Study Design

The researchers employed a genetic-driven approach to identify the two obesity profiles. They then conducted a **phenome-wide comparative analysis** to annotate and compare the genetic association signals for these profiles across various clinical and molecular phenotypic layers.

* **Data Sources:** The analysis utilized individual-level data from large biobanks, specifically the **UK Biobank** and **BioVU**.
* **Ethics:** The study adhered to the ethical principles of the Declaration of Helsinki, with both data sources having received the necessary institutional ethics approvals, and all participants providing written informed consent.

## Results: Phenotypic Differences

The comparative analysis identified key differences between the two obesity profiles across a wide spectrum of traits, illustrating the diverse pathways through which obesity can influence health.

### Trait Discordance
Significant differences were identified in various clinical and molecular traits, including:
* **Cardiovascular Mortality:** The profiles convey different risks for cardiovascular outcomes.
* **Fat Distribution:** Variations were observed in how fat is distributed in the body.
* **Metabolism:** Key differences were found in **liver metabolism**, **blood pressure**, and specific **lipid fractions**.
* **Molecular Traits:** Differences were noted in blood levels of proteins involved in **extracellular matrix remodelling**.
* **Microbiome:** Marginal differences were found in the abundance of *Bacteroidetes* and *Firmicutes* bacteria in the gut.

### Causal Mechanisms
Instrumental analyses indicated prominent **causal roles** for certain risk factors in driving the discordance between the profiles:
* **Waist-to-Hip Ratio (WHR):** This measure of central adiposity plays a key causal role.
* **Blood Pressure:** Elevated blood pressure is a prominent causal factor.
* **Cholesterol Content of High-Density Lipoprotein (HDL):** The genetic influence on HDL cholesterol content is also a significant causal differentiator.

## Conclusions

The research defines a genetic basis for the **heterogeneity** observed in the relationship between obesity and T2D. By identifying obesity profiles with distinct diabetogenic effects and differential impacts on cardiovascular and metabolic health, the study supports a more refined, mechanism-based approach to understanding and treating T2D risk. This paves the way for a precision medicine framework where genetic profiles could inform specific intervention strategies.